Practice
Featured experience
Amazon.com $15 billion notes offering
We advised the underwriters on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
SailPoint $1.4 billion IPO
The shares are listed on the Nasdaq Global Select Market
Humanigen stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with…
Marcus $100.05 million convertible senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by The Marcus…
Nuvei $805 million IPO
Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares…
Vitru $96 million IPO and Nasdaq listing
Davis Polk advised Vitru Limited in connection with its initial public offering of an aggregate of 6,000,000 common shares…
JPMorgan Chase $6.8 billion cash tender offer
Davis Polk advised JPMorgan Chase & Co. in connection with its cash tender offer to purchase certain of its senior debt…
American Well $853 million IPO and NYSE listing
Davis Polk advised American Well Corporation (“Amwell”) in connection with its initial public offering of 47,405,555 shares…
Chewy $282 million public offering
Davis Polk advised the underwriter in connection with a $282 million public offering of 5,100,000 shares of Class A…
Discovery Communications exchange offers of notes
Davis Polk advised the joint-lead dealer managers and the co-dealer managers in connection with the Rule 144A/Regulation S…
JPMorgan Chase euro medium-term note program
Davis Polk advised JPMorgan Chase & Co. in connection with the update of a Euro medium-term note program under which…
Pactiv Evergreen $574 million IPO
Davis Polk advised Pactiv Evergreen Inc. (formerly known as Reynolds Group Holdings Limited) on its $574 million initial…